Aptissen SA
Catherine A. Schütz is an R&D and Clinical Project Manager at Aptissen SA since January 2023, previously serving as a Clinical Trial Manager at ObsEva SA from September 2016 to November 2022. At ObsEva, Catherine managed clinical trial activities, including study setup, service provider management, and regulatory documentation. Catherine’s experience at PAREXEL from January 2013 to March 2016 encompassed roles as Project Specialist II and I, focusing on clinical trial project management and compliance. Catherine began their career with research roles, including positions at CHUV and EPFL, where extensive research activities culminated in a PhD in Life Science, with a focus on hydrophilic nanogels. Educational qualifications include a PhD and a combined BSc and MSc in Material Science and Engineering from Ecole Polytechnique Fédérale de Lausanne.
This person is not in any teams
Aptissen SA
Aptissen S.A. is a Swiss company specialized in the development and commercialization of biopolymer-based medical devices. Aptissen’s founders have developed for the past 25 years the best quality injectable products which meet both patients and doctors expectations: www.aptissen.com The company was founded in 2013 as a spin-off of ANTEIS, and is based in Geneva area, Switzerland. It today distributes its products through a worldwide international distributors' network among more than 90 countries including Europe, South America, Canada, Middle East and Asia. Aptissen's team revolutionized the viscosupplement market with Synolis VA and his patented formulation which combines Hyaluronic Acid and Sorbitol. Synolis VA provides rapid mobility recovery, fast long lasting pain relief associated with excellent safety: www.synolis.com We place the patient benefit at the center of our mission to develop innovative injectable solutions based on hyaluronic acid to provide fast pain relief.